Condition
Tick Paralysis
Editors: Paritosh Prasad MD
Background Information
Description
Also called
- tick toxicosis
Epidemiology
Geographic distribution
Incidence/Prevalence
- rare(,,)
- not a reportable illness so precise incidence not known and likely underestimated
- at least 50 well-documented cases between 1946 and 2006
- 4 cases reported in north-central Colorado in May 2006 (MMWR Morb Mortal Wkly Rep 2006 Sep 1;55(34):933)
- Neurologic_Disordersrates in United States and Australia generally < 1 case/year (Clin Toxicol (Phila) 2015 Nov)05/31/2017 07:11:00 PM26359765 rates in United States and Australia generally < 1 case/year
- 55 cases reported in United States between 1946 and 2014
- 35 cases reported in Australia between 1904 and 2009
- Reference - Clin Toxicol (Phila) 2015 Nov;53(9):874
- most cases occur in spring and summer (peak tick season)(,,)
Likely risk factors
- activities associated with potential tick exposure such as
- hiking
- camping
- living in or traveling to endemic areas
Etiology and Pathogenesis
Causes
Pathogenesis
- salivary neurotoxin, holocyclotoxin, transmitted from tick to human during a blood meal(,)
- holocyclotoxin likely acts by decreasing acetylcholine release at the neuromuscular junction
- mechanism of action thought similar to that of botulinum toxin
- toxin from tick in Australian variant may act differently
- as tick feeds, toxin increases in concentration()
- symptoms of paralysis begin about 2-7 days after bite (mean 5 days)(,)
Published by EBSCO Information Services. Copyright © 2025, EBSCO Information Services. All rights reserved. No part of this may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission.
EBSCO Information Services accepts no liability for advice or information given herein or errors/omissions in the text. It is merely intended as a general informational overview of the subject for the healthcare professional.
DynaMed Levels of Evidence
Quickly find and determine the quality of the evidence.
DynaMed provides easy-to-interpret Level of Evidence labels so users can quickly find and determine the quality of the best available evidence. Evidence may be labeled in one of three levels:
1Level 1 (likely reliable) Evidence
2Level 2 (mid-level) Evidence
3Level 3 (lacking direct) Evidence
Grades of Recommendation
Guideline producers are now frequently using classification approaches for their evidence and recommendations, and these classifications are recognized and requested by guideline users. When summarizing guideline recommendations for DynaMed users, the DynaMed Editors are using the guideline-specific classifications and providing guideline classification approach when this is done.
Download the full version of Levels of Evidence